Oral hypericin antiviral: Announced a protocol for a Phase I/II trial

VIMRx Pharmaceuticals Inc. (VMRX), Stamford, Conn. Product: Oral hypericin antiviral Indication: HIV infection Status: Announced a lower dosing protocol for a Phase I/II trial that will be implemented...